(Date:12/3/2009)SAN FRANCISCO, Dec. 3 VIA Pharmaceuticals, Inc. (Nasdaq: VIAP ), a biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic disease, today anno
(Date:12/3/2009)NEW DELHI, India, Dec. 3 /PRNewswire-Asia/ -- Dr. Susan Jiang, M.D., Ph.D.,Chief Science Officer at Shenzhen Beike Biotechnology Co. Ltd.,( http://www.beikebiotech.com ), spoke at a conference on Hig
(Date:12/2/2009)NEW YORK, Dec. 2 Reportlinker.com announces that a new market research report is available in its catalogue: ,, Drug Discovery Technologies - A Global Update of Market Trends & Opportunities ,,
(Date:12/2/2009)LIBREVILLE, Gabon, December 2 , - "Bolstering Biodiversity in Africa: Everyone,s Problem and Heritage" , Coinciding with the International Year of Biodiversity, 2-3 June 2010 the,Gabonese Rep
Breaking Biology Technology:VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 3VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 4Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9Libreville International Conference 2-3 June 2010 2Gerresheimer Substantially Increases Quarterly Operating Profit
Vineland Welcomes Dr. Daryl Somers as Research Chair, Molecular Breeding and Biotechnology
...se Biologic Product to Debut at NASS, GREENVILLE,... Technology, Inc. today announced the U.S. market ...he novel biologic will make its public,debut at th...Society (NASS),in Toronto, Canada. The FortrOss bo...ogy for orthopaedic applications, is a scaffold fo...
Other Biology Technology:Gerresheimer Substantially Increases Quarterly Operating Profit 2Gerresheimer Substantially Increases Quarterly Operating Profit 3Gerresheimer Substantially Increases Quarterly Operating Profit 4Gerresheimer Substantially Increases Quarterly Operating Profit 5Vineland Welcomes Dr. Daryl Somers as Research Chair, Molecular Breeding and Biotechnology 2Pioneer(R) Surgical Technology Announces Market Release of FortrOss(TM), a Next Generation Bone Void Filler 2...itor Assay Kits are ideal for studying or screenin...ing fluorescence polarization (FP) The homogenous ... to the ligand binding domain of human progesteron...scently-tagged progesterone ligand, Fluormone PL G...
...ifically to Fc regions of many mammalian immunoglo...monly used as affinity adsorbents to purify immuno... from serum, hybridoma ascites fluids, tissue cult...e reagents are also commonly used to capture immun...
...rument engineered to match the speed of biochemica...enters worldwide. It uses 1.5 mm Roche LightCycler...-speed temperature cycling due to their thin walls...,By combining glass capillary tubes and air as th...
Freund's Incomplete Adjuvant, Modified from Calbiochem
Biology Products: